Intercept Pharmaceuticals Inc entered the industry of in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 2834 and described it as a . The business provides service to the BOTH market.
To acquire more information, please contact Mark Pruzanski, Chief Executive Officer by calling (646) 747-1000 during business hours. You can also write to the business’ Headquarters at 18 Desbrosses St Front 1, New York City, New York NY 10013. You can also visit the company’s website at interceptpharma.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Intercept Pharmaceuticals Inc |
Representative: | Mark Pruzanski, Chief Executive Officer |
Place of Business: | 18 Desbrosses St Front 1, New York City, NY 10013 |
Contact Number: | (646) 747-1000 |
Website: | interceptpharma.com |
Type of Service: | |
SIC Number: | 2834 |
NAICS Number: | 4461100 |
Locality: | Headquarters |
Market Type: | B2B & B2C |
Began: | 2002 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Intercept Pharmaceuticals Inc is a company operating from New York, New York providing professional and relevant BOTH variables. It was founded in 2002 and registered with the SIC code 2834 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Intercept Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Mark Pruzanski, Chief Executive Officer at (646) 747-1000 for related queries, or to locate its Headquarters using the coordinates 40.723407,-74.00922.
The Headquarters can also be found at the street address 18 Desbrosses St Front 1 in New York City, New York 10013 and can be engaged online through the company website at interceptpharma.com, the company Twitter , and Facebook page .